1. Wilson, C, X Ye, T Pham, E Lin, S Chan, E McNamara, R M Neve, et al. 2014. AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs. Cancer Research 74 (20): 5878–90.
2. Brand, Toni M, Mari Iida, Kelsey L Corrigan, Cara M Braverman, John P Coan, Bailey G Flanigan, Andrew P Stein, et al. 2017. The Receptor Tyrosine Kinase AXL Mediates Nuclear Translocation of the Epidermal Growth Factor Receptor. Sci. Signal. 10 (460). American Association for the Advancement of Science: eaag1064.